Nacalai USA entered into a distribution agreement with LifeSensors related to the latter’s Ubiquitin Proteasome Pathway (UPP) research tools and recombinant protein-expression technologies in Japan, Singapore, South Korea, and Taiwan.


San Diego-based Nacalai USA and its parent company Nacalai Tesque, a Japanese life science research reagent and chemical company headquartered in Kyoto, will facilitate distribution in these regions.








This site uses Akismet to reduce spam. Learn how your comment data is processed.